http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6927064-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6aae2d076b079299bda5091c3786a99a
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01L2200-12
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B10-0012
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61D17-002
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B10-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61D17-00
filingDate 2000-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2005-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7eef54ecfa2f1d89326dba0dc8774198
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d2fde00c6d7e5d9096f32265d86c270c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_213dcdaa0fd96ccfbf64f5573d9ef0aa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ee59361a7476c2d17084d5cd8b062711
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fa4fa9645671de1c58e6274f94816443
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_521da0f8154389867b28e884fbf07c8c
publicationDate 2005-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-6927064-B1
titleOfInvention Fertility computing method
abstract A fertility determining system employing hormone level measuring apparatus on selected days in a menstrual cycle to determine the levels of analytes, i.e., estrone-3-glucuronide (“E3G”) and luteinizing hormone (“LH”), in early morning urine. The fertility/infertility signalling algorithm relies upon data characterizing the user earlier in that menstrual cycle, and also upon her analyte pattern in past recent cycles. At a point in a menstrual cycle which is user-dependent, the early morning E3G urine level is compared against the lower E3G level earlier in the cycle. The beginning of the fertile period is signalled when a sufficient E3G increase occurs. The end of the fertile period (and, correspondingly, the reestablishment of a period requiring no contraception) is signalled a period after the LH surge. In the absence of an LH surge in any subject, the end of the fertile phase is signalled a period of time following the peak of the E3G urinary metabolite of estradiol.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8221328-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9939385-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7977103-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8486717-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11016090-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8835184-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2465469-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9851366-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10670533-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9199232-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9599615-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8702618-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011171754-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9588113-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9874556-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9874576-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10352946-B2
priorityDate 1994-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0383619-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5508261-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3986494-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6451619-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4036212-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5837197-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4693969-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9402850-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5657762-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4151833-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5118630-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6234974-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4292315-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0653625-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4010738-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4291028-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4465077-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4119089-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5467778-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6454726-B1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID115255
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399323
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227163030
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13783435
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127854429
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5757
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447980235
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID108710621
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415816928
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID159383

Total number of triples: 67.